December 5-8, 2020; Online at https://www.hematology.org/meetings/annual-meeting
Results from this phase III study of mycophenolate mofetil and a short course of corticosteroids vs corticosteroids alone as first-line treatment for patients with ITP shows the combination therapy to be safe and effective, reducing the rate of treatment failure by more than one half.